Literature DB >> 27956933

Anti-GQ1b-Negative Miller Fisher Syndrome with Acute Areflexic Mydriasis and Cholinergic Supersensitivity.

Özlem Kayım Yıldız1, Hatice Balaban1, Sibel Özdemir1, Ertuğrul Bolayır1, Suat Topaktas1.   

Abstract

Miller Fisher syndrome is a rare variant of Guillain-Barré syndrome and it is characterised by ophthalmoplegia, ataxia, and areflexia. Pupillomotor involvement occurs in approximately half of the patients with the disorder. The authors report a patient with acute areflexic mydriasis, external ophthalmoplegia, areflexia, and ataxia. Although the pupils were unreactive to light and near stimuli, administration of 0.1% pilocarpine resulted in marked miosis, suggesting cholinergic supersensitivity. Antibodies against GM1, GD1b, and GQ1b were negative. This is the first report of acute areflexic mydriasis with cholinergic supersensitivity in anti-GQ1b-negative Miller Fisher syndrome.

Entities:  

Keywords:  Miller Fisher syndrome; anti-GQ1b; cholinergic supersensitivity; mydriasis

Year:  2011        PMID: 27956933      PMCID: PMC5145285          DOI: 10.3109/01658107.2010.539761

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  10 in total

1.  Clinical features and prognosis of Miller Fisher syndrome.

Authors:  M Mori; S Kuwabara; T Fukutake; N Yuki; T Hattori
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

2.  Comparison of cholinergic supersensitivity in third nerve palsy and Adie's syndrome.

Authors:  D M Jacobson; R A Vierkant
Journal:  J Neuroophthalmol       Date:  1998-09       Impact factor: 3.042

3.  Frequent presence of anti-GQ1b antibody in Fisher's syndrome.

Authors:  N Yuki; S Sato; S Tsuji; T Ohsawa; T Miyatake
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

4.  The tonic pupil: a re-evaluation.

Authors:  I E Loewenfeld; H S Thompson
Journal:  Am J Ophthalmol       Date:  1967-01       Impact factor: 5.258

5.  Segmental denervation and reinnervation of the iris sphincter as shown by infrared videographic transillumination.

Authors:  R H Kardon; J J Corbett; H S Thompson
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

Review 6.  The Fisher variant of Guillain-Barré syndrome (Fisher syndrome).

Authors:  Lee A Snyder; Vivian Rismondo; Neil R Miller
Journal:  J Neuroophthalmol       Date:  2009-12       Impact factor: 3.042

7.  Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody.

Authors:  S-H Lee; G-H Lim; J S Kim; S-Y Oh; J K Kim; J-K Cha; C-H Yun; J K Kang; H Lee; H-K Song; K C Chung
Journal:  Neurology       Date:  2008-08-05       Impact factor: 9.910

Review 8.  Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses.

Authors:  H Rauschka; K Jellinger; H Lassmann; F Braier; M Schmidbauer
Journal:  Eur J Neurol       Date:  2003-09       Impact factor: 6.089

9.  Mydriasis with light-near dissociation in Fisher's Syndrome.

Authors:  Takuya Nitta; Manabu Kase; Yasuhiro Shinmei; Kazuhiko Yoshida; Shinki Chin; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

10.  Tonic pupils with acute ophthalmoplegic polyneuritis.

Authors:  J R Keane
Journal:  Ann Neurol       Date:  1977-11       Impact factor: 10.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.